Meibomian Blepharitis drugs in development, 2023

GlobalData tracks 5 drugs in development for Meibomian Blepharitis by six companies/universities/institutes. The top development phase for Meibomian Blepharitis is phase ii, with three drugs in that stage.

New evidence challenges hype surrounding cancer blood test

New evidence published by The BMJ today casts doubt on a much-hyped blood test for the NHS that promises to detect more than 50 types

August 8, 2024

PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care – Biotech Investments

bonyf NV / Key word(s): Product Launch/Research Update PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care 24-Oct-2024 / 11:48 CET/CEST PerioTabs®: Innovative 10-Day NitrAdine®-Based

October 25, 2024

FDA declines to approve Satsuma’s migraine treatment STS101

Share this article STS101 is designed to be an easy-to-use and portable treatment option for migraine patients. Credit: Photoroyalty / Shutterstock.com. The US Food and

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.